celiprolol has been researched along with Hypertrophy, Left Ventricular in 3 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was undertaken to clarify whether celiprolol and atenolol, beta1-selective beta blockers with and without intrinsic sympathomimetic activity (ISA), respectively, might improve ischemic damage in the isolated perfused hearts of spontaneously hypertensive rats (SHR), and whether long-term treatment with celiprolol may reduce left ventricular hypertrophy (LVH) in patients with essential hypertension." | 9.09 | Effect of celiprolol on cardiac hypertrophy in hypertension. ( Haneda, T; Honda, H; Kataoka, R; Kato, J; Kikuchi, K; Matsuhashi, H; Morimoto, H; Ogawa, Y; Takenaka, T; Tanazawa, S, 2000) |
| "The present study was undertaken to clarify whether celiprolol and atenolol, beta1-selective beta blockers with and without intrinsic sympathomimetic activity (ISA), respectively, might improve ischemic damage in the isolated perfused hearts of spontaneously hypertensive rats (SHR), and whether long-term treatment with celiprolol may reduce left ventricular hypertrophy (LVH) in patients with essential hypertension." | 5.09 | Effect of celiprolol on cardiac hypertrophy in hypertension. ( Haneda, T; Honda, H; Kataoka, R; Kato, J; Kikuchi, K; Matsuhashi, H; Morimoto, H; Ogawa, Y; Takenaka, T; Tanazawa, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, M | 1 |
| Horinaka, S | 1 |
| Komatsu, K | 1 |
| Frohlich, ED | 1 |
| Vyssoulis, GP | 1 |
| Kouremetis, MT | 1 |
| Valiouli, MA | 1 |
| Michaelides, AP | 1 |
| Toutouzas, PK | 1 |
| Haneda, T | 1 |
| Ogawa, Y | 1 |
| Kato, J | 1 |
| Matsuhashi, H | 1 |
| Morimoto, H | 1 |
| Honda, H | 1 |
| Takenaka, T | 1 |
| Tanazawa, S | 1 |
| Kataoka, R | 1 |
| Kikuchi, K | 1 |
2 trials available for celiprolol and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effect of beta-blockade on exercise capacity in hypertensive subjects: a one-year double-blind study of celiprolol and metoprolol.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; Celiprolol; Double-Blind Method; Echocardiography; Ele | 1995 |
Effect of celiprolol on cardiac hypertrophy in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Celi | 2000 |
1 other study available for celiprolol and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Reversal of left ventricular hypertrophy with different classes of drugs causes differing ventricular biochemical changes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Celiprolol | 1993 |